JO3040B1 - ترايازولوبيريدينات - Google Patents
ترايازولوبيريديناتInfo
- Publication number
- JO3040B1 JO3040B1 JOP/2012/0093A JOP20120093A JO3040B1 JO 3040 B1 JO3040 B1 JO 3040B1 JO P20120093 A JOP20120093 A JO P20120093A JO 3040 B1 JO3040 B1 JO 3040B1
- Authority
- JO
- Jordan
- Prior art keywords
- compounds
- triazolopyridines
- prophylaxis
- disease
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
يتعلق الاختراع الحالي بمركبات triazolopyridine من الصيغة العامة (I): (I) حيث R1، R2، R3، R4، وR5 كما هو موضح في الوصف وفي عناصر الحماية، بطرق لتحضير المركبات المذكورة، بتركيبات دوائية واتحادات تشمل المركبات المذكورة، باستخدام المركبات المذكورة لتصنيع تركيبة دوائية لمعالجة أو الوقاية من مرض، بالإضافة إلى مركبات وسطية مفيدة في تحضير المركبات المذكورة.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11163342 | 2011-04-21 | ||
EP11167872 | 2011-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
JO3040B1 true JO3040B1 (ar) | 2016-09-05 |
Family
ID=46124297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2012/0093A JO3040B1 (ar) | 2011-04-21 | 2012-04-18 | ترايازولوبيريدينات |
Country Status (39)
Country | Link |
---|---|
US (1) | US20140120087A1 (ar) |
EP (1) | EP2699575B1 (ar) |
JP (1) | JP5989091B2 (ar) |
KR (1) | KR20140025470A (ar) |
CN (1) | CN103608350B (ar) |
AP (1) | AP3491A (ar) |
AR (1) | AR086191A1 (ar) |
AU (1) | AU2012244859B2 (ar) |
CA (1) | CA2833657A1 (ar) |
CL (1) | CL2013003044A1 (ar) |
CO (1) | CO6801751A2 (ar) |
CR (1) | CR20130539A (ar) |
CY (1) | CY1116439T1 (ar) |
DK (1) | DK2699575T3 (ar) |
DO (1) | DOP2013000244A (ar) |
EA (1) | EA023766B1 (ar) |
EC (1) | ECSP13013011A (ar) |
ES (1) | ES2539265T3 (ar) |
GT (1) | GT201300254A (ar) |
HK (1) | HK1190398A1 (ar) |
HR (1) | HRP20150517T1 (ar) |
HU (1) | HUE025496T2 (ar) |
IL (1) | IL228704A0 (ar) |
JO (1) | JO3040B1 (ar) |
MA (1) | MA35049B1 (ar) |
ME (1) | ME02143B (ar) |
MX (1) | MX348783B (ar) |
MY (1) | MY164939A (ar) |
PE (1) | PE20141351A1 (ar) |
PL (1) | PL2699575T3 (ar) |
PT (1) | PT2699575E (ar) |
RS (1) | RS54044B1 (ar) |
SA (1) | SA112330466B1 (ar) |
SG (1) | SG194003A1 (ar) |
SI (1) | SI2699575T1 (ar) |
TW (1) | TWI558703B (ar) |
UY (1) | UY34034A (ar) |
WO (1) | WO2012143329A1 (ar) |
ZA (1) | ZA201308707B (ar) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP2015008931A0 (en) | 2011-04-21 | 2015-12-31 | Gilead Sciences Inc | Benzothiazole compounds and their pharmaceutical use |
UA112096C2 (uk) * | 2011-12-12 | 2016-07-25 | Байєр Інтеллектуал Проперті Гмбх | Заміщені триазолопіридини та їх застосування як інгібіторів ttk |
WO2013103738A1 (en) | 2012-01-04 | 2013-07-11 | Gilead Sciences, Inc. | Napthalene acetic acid derivatives against hiv infection |
WO2013103724A1 (en) | 2012-01-04 | 2013-07-11 | Gilead Sciences, Inc. | 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids |
WO2013135612A1 (en) | 2012-03-14 | 2013-09-19 | Bayer Intellectual Property Gmbh | Substituted imidazopyridazines |
KR20150040845A (ko) * | 2012-07-10 | 2015-04-15 | 바이엘 파마 악티엔게젤샤프트 | 치환된 트리아졸로피리딘을 제조하는 방법 |
WO2014020041A1 (en) | 2012-08-02 | 2014-02-06 | Bayer Pharma Aktiengesellschaft | Combinations for the treatment of cancer |
WO2014020043A1 (en) | 2012-08-02 | 2014-02-06 | Bayer Pharma Aktiengesellschaft | Combinations for the treatment of cancer |
CN105408332B (zh) * | 2013-06-07 | 2017-05-10 | 拜耳制药股份公司 | 取代的三唑并吡啶类 |
CA2914521A1 (en) * | 2013-06-07 | 2014-12-11 | Bayer Pharma Aktiengesellschaft | Substituted triazolopyridines having activity as mps-1 inhibitors |
EP3008061A1 (en) * | 2013-06-10 | 2016-04-20 | Bayer Pharma Aktiengesellschaft | Novel compounds for the treatment of cancer |
WO2014198645A1 (en) * | 2013-06-11 | 2014-12-18 | Bayer Pharma Aktiengesellschaft | Combinations for the treatment of cancer comprising a mps-1 kinase inhibitor and a mitotic inhibitor |
JP2016526534A (ja) | 2013-06-11 | 2016-09-05 | バイエル・ファルマ・アクティエンゲゼルシャフト | 置換トリアゾロピリジンのプロドラッグ誘導体 |
EP2860177A3 (en) | 2013-09-20 | 2015-06-10 | Bayer Intellectual Property GmbH | Synthesis of functionalized arenes |
WO2016166255A1 (en) | 2015-04-17 | 2016-10-20 | Netherlands Translational Research Center B.V. | Prognostic biomarkers for ttk inhibitor chemotherapy |
UA125592C2 (uk) * | 2017-03-16 | 2022-04-27 | Джянгсу Хенгруй Медісін Ко., Лтд. | ПОХІДНА ГЕТЕРОАРИЛ[4,3-c]ПІРИМІДИН-5-АМІНУ, СПОСІБ ЇЇ ОТРИМАННЯ ТА ЇЇ МЕДИЧНІ ЗАСТОСУВАННЯ |
AU2020257301A1 (en) | 2019-04-18 | 2021-11-11 | The Johns Hopkins University | Substituted 2-amino-pyrazolyl-(1,2,4)triazolo(1,5a) pyridine derivatives and use thereof |
AU2020300619A1 (en) | 2019-07-03 | 2022-01-27 | Sumitomo Pharma Oncology, Inc. | Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
US5011472A (en) | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
ES2315909T3 (es) | 2004-08-17 | 2009-04-01 | GALDERMA RESEARCH & DEVELOPMENT | Nuevos compuestos bioaromaticos que son activadores de los receptores del tipo ppar y su utilizacion en composiciones cosmeticas y farmaceuticas. |
SG174086A1 (en) * | 2006-08-30 | 2011-09-29 | Cellzome Ltd | Triazole derivatives as kinase inhibitors |
AU2008277628B2 (en) * | 2007-07-18 | 2012-03-15 | Novartis Ag | Bicyclic heteroaryl compounds and their use as kinase inhibitors |
MX2010002115A (es) | 2007-08-23 | 2010-06-01 | Aztrazeneca Ab | 2-anilinopurin-8-onas como inhibidores de ttk/mps1 para el tratamiento de trastornos .proliferativos. |
WO2009027283A1 (en) | 2007-08-31 | 2009-03-05 | Merck Serono S.A. | Triazolopyridine compounds and their use as ask inhibitors |
GB0719803D0 (en) | 2007-10-10 | 2007-11-21 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
CN101952285A (zh) * | 2007-11-27 | 2011-01-19 | 塞尔卓姆有限公司 | 作为pi3k抑制剂的氨基三唑 |
WO2010092041A1 (en) * | 2009-02-13 | 2010-08-19 | Fovea Pharmaceuticals Sa | [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors |
CN102413831B (zh) | 2009-04-29 | 2014-06-04 | 拜耳知识产权有限责任公司 | 取代的咪唑并喹喔啉 |
CA2772790C (en) | 2009-09-04 | 2017-06-27 | Benjamin Bader | Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors |
EP2343297A1 (en) * | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Triazolopyridines |
UY33452A (es) * | 2010-06-16 | 2012-01-31 | Bayer Schering Pharma Ag | Triazolopiridinas sustituidas |
-
2012
- 2012-04-16 US US14/113,017 patent/US20140120087A1/en not_active Abandoned
- 2012-04-16 PT PT127217792T patent/PT2699575E/pt unknown
- 2012-04-16 AP AP2013007182A patent/AP3491A/xx active
- 2012-04-16 SG SG2013073044A patent/SG194003A1/en unknown
- 2012-04-16 RS RS20150345A patent/RS54044B1/en unknown
- 2012-04-16 CN CN201280030682.XA patent/CN103608350B/zh not_active Expired - Fee Related
- 2012-04-16 SI SI201230220T patent/SI2699575T1/sl unknown
- 2012-04-16 PE PE2013002378A patent/PE20141351A1/es not_active Application Discontinuation
- 2012-04-16 KR KR1020137030546A patent/KR20140025470A/ko not_active Application Discontinuation
- 2012-04-16 ME MEP-2015-80A patent/ME02143B/me unknown
- 2012-04-16 MX MX2013012289A patent/MX348783B/es active IP Right Grant
- 2012-04-16 HU HUE12721779A patent/HUE025496T2/en unknown
- 2012-04-16 DK DK12721779.2T patent/DK2699575T3/da active
- 2012-04-16 MY MYPI2013701964A patent/MY164939A/en unknown
- 2012-04-16 JP JP2014505584A patent/JP5989091B2/ja not_active Expired - Fee Related
- 2012-04-16 AU AU2012244859A patent/AU2012244859B2/en not_active Ceased
- 2012-04-16 EA EA201301181A patent/EA023766B1/ru not_active IP Right Cessation
- 2012-04-16 PL PL12721779T patent/PL2699575T3/pl unknown
- 2012-04-16 MA MA36344A patent/MA35049B1/fr unknown
- 2012-04-16 ES ES12721779.2T patent/ES2539265T3/es active Active
- 2012-04-16 CA CA2833657A patent/CA2833657A1/en not_active Abandoned
- 2012-04-16 WO PCT/EP2012/056914 patent/WO2012143329A1/en active Application Filing
- 2012-04-16 EP EP12721779.2A patent/EP2699575B1/en active Active
- 2012-04-18 SA SA112330466A patent/SA112330466B1/ar unknown
- 2012-04-18 JO JOP/2012/0093A patent/JO3040B1/ar active
- 2012-04-20 UY UY0001034034A patent/UY34034A/es not_active Application Discontinuation
- 2012-04-20 AR ARP120101355A patent/AR086191A1/es active Pending
- 2012-04-20 TW TW101114259A patent/TWI558703B/zh not_active IP Right Cessation
-
2013
- 2013-10-03 IL IL228704A patent/IL228704A0/en unknown
- 2013-10-18 GT GT201300254A patent/GT201300254A/es unknown
- 2013-10-21 CR CR20130539A patent/CR20130539A/es unknown
- 2013-10-21 CO CO13248763A patent/CO6801751A2/es active IP Right Grant
- 2013-10-21 DO DO2013000244A patent/DOP2013000244A/es unknown
- 2013-10-21 CL CL2013003044A patent/CL2013003044A1/es unknown
- 2013-11-05 EC ECSP13013011 patent/ECSP13013011A/es unknown
- 2013-11-20 ZA ZA2013/08707A patent/ZA201308707B/en unknown
-
2014
- 2014-04-15 HK HK14103581.3A patent/HK1190398A1/zh not_active IP Right Cessation
-
2015
- 2015-05-14 HR HRP20150517TT patent/HRP20150517T1/hr unknown
- 2015-06-12 CY CY20151100512T patent/CY1116439T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JO3040B1 (ar) | ترايازولوبيريدينات | |
TN2014000254A1 (en) | Substituted triazolopyridines and their use as ttk inhibitors | |
TN2012000595A1 (en) | Substituted triazolopyridines | |
TN2012000265A1 (en) | Triazolopyridines | |
PH12016501581A1 (en) | Benzimidazol-2-amines as midh1 inhibitors | |
MY185139A (en) | Substituted imidazopyridazines | |
MY168413A (en) | Amino-substituted imidazopyridazines | |
IN2012DN02139A (ar) | ||
MX2019012939A (es) | Formulaciones que contienen linaclotida para administracion oral. | |
PH12016500054A1 (en) | Substituted pyrazolo-pyridinamines | |
MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
PH12015502747A1 (en) | Novel compounds for the treatment of cancer | |
PH12015500061A1 (en) | Method for preparing substituted triazolopyridines | |
PH12015502703A1 (en) | Pharmaceutical compositions | |
TN2013000426A1 (en) | Triazolopyridines | |
SA112330437B1 (ar) | تركيبات دوائية محتوية على عامل منوم او مخدر وطريقة تحضيرها |